Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Animals (Basel) ; 13(24)2023 Dec 05.
Article in English | MEDLINE | ID: mdl-38136789

ABSTRACT

An 8-year-old female Domestic Shorthair presented with signs of intracranial disease. Magnetic resonance imaging (MRI) of the head showed an extra-axial space-occupying mass within the cranial vault with a similar intensity lesion within the overlying temporalis muscle. Postmortem examination found masses within the head, lung, liver, spleen, and kidney consistent with malignant melanoma. Intracranial melanoma is rarely reported in cats and is typically only seen as a metastatic lesion associated with an ocular mass. Melanomas can be readily recognised on MRI as they are one of the few lesions which are hyperintense on T1-weighted images.

2.
Vet Clin Pathol ; 43(2): 164-71, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24750485

ABSTRACT

BACKGROUND: Quality control (QC) validation is an essential tool in total quality management of a veterinary clinical pathology laboratory. Cost-analysis can be a valuable technique to help identify an appropriate QC procedure for the laboratory, although this has never been reported in veterinary medicine. OBJECTIVE: The aim of this study was to determine the applicability of the Six Sigma Quality Cost Worksheets in the evaluation of possible candidate QC rules identified by QC validation. METHODS: Three months of internal QC records were analyzed. EZ Rules 3 software was used to evaluate candidate QC procedures, and the costs associated with the application of different QC rules were calculated using the Six Sigma Quality Cost Worksheets. The costs associated with the current and the candidate QC rules were compared, and the amount of cost savings was calculated. RESULTS: There was a significant saving when the candidate 1-2.5s, n = 3 rule was applied instead of the currently utilized 1-2s, n = 3 rule. The savings were 75% per year (£ 8232.5) based on re-evaluating all of the patient samples in addition to the controls, and 72% per year (£ 822.4) based on re-analyzing only the control materials. The savings were also shown to change accordingly with the number of samples analyzed and with the number of daily QC procedures performed. CONCLUSIONS: These calculations demonstrated the importance of the selection of an appropriate QC procedure, and the usefulness of the Six Sigma Costs Worksheet in determining the most cost-effective rule(s) when several candidate rules are identified by QC validation.


Subject(s)
Hematology/standards , Laboratories/standards , Pathology, Veterinary/standards , Animals , Blood Cell Count/economics , Blood Cell Count/instrumentation , Blood Cell Count/standards , Costs and Cost Analysis , Hematology/economics , Hematology/instrumentation , Laboratories/economics , Pathology, Veterinary/economics , Pathology, Veterinary/methods , Quality Control , Software
3.
Vet Clin Pathol ; 41(4): 493-6, 2012 Dec.
Article in English | MEDLINE | ID: mdl-23130935

ABSTRACT

An 8-year-old Jack Russell Terrier was diagnosed with hemolytic anemia caused by hemoplasmosis 4 years following splenectomy. Quantitative real-time PCR (qPCR) analysis was used initially to confirm infection with Mycoplasma haemocanis and subsequently to monitor and direct medical therapy. Doxycycline was administered beyond resolution of clinical signs until hemoplasma DNA could no longer be detected by qPCR. The dog remained clinically healthy and hemoplasma-negative 8 months following cessation of therapy. Canine hemoplasmosis should remain as a differential diagnosis for hemolytic anemia in dogs, particularly those that are splenectomized or immunocompromised, even in geographic regions where prevalence of infection is low. Prolonged doxycycline administration has been shown by qPCR to lead to sustained absence of detectable infection and should be considered as a first line treatment for canine hemoplasmosis.


Subject(s)
Anti-Bacterial Agents/administration & dosage , Dog Diseases/drug therapy , Doxycycline/administration & dosage , Mycoplasma Infections/veterinary , Mycoplasma/isolation & purification , Real-Time Polymerase Chain Reaction/veterinary , Anemia, Hemolytic/drug therapy , Anemia, Hemolytic/parasitology , Anemia, Hemolytic/veterinary , Animals , DNA, Bacterial/genetics , Diagnosis, Differential , Dog Diseases/parasitology , Dogs , Erythrocytes/cytology , Erythrocytes/parasitology , Male , Mycoplasma/drug effects , Mycoplasma/genetics , Mycoplasma Infections/drug therapy , Mycoplasma Infections/parasitology , Splenectomy/veterinary , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...